Related Experiment Video
Updated: May 12, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
[Hypertrophic cardiomyopathy: current aspects and new developments]
1Hôpital Européen Georges Pompidou, 20, rue Leblanc - 75015 Paris. michel.desnos@egp.aphp.fr
Insights
Hypertrophic cardiomyopathy (HCM) is a genetic heart condition causing thickened heart muscle. It is a leading cause of sudden cardiac death in young individuals, necessitating genetic counseling and risk stratification.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Context:
- Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder.
- Diagnosis relies on cardiac imaging like echocardiography and cardiac MRI.
- HCM is the most common inherited cardiovascular disease and a leading cause of sudden cardiac death in young individuals.
Purpose:
- To provide a comprehensive overview of Hypertrophic Cardiomyopathy (HCM).
- To discuss the genetic basis, clinical presentation, diagnosis, and management of HCM.
- To highlight the importance of risk stratification and current treatment strategies.
Summary:
- HCM is an autosomal dominant genetic disorder caused by mutations in sarcomeric protein genes, leading to left ventricular hypertrophy.
- Clinical manifestations range from asymptomatic to severe heart failure, atrial fibrillation, stroke, and sudden cardiac death.
- Management includes medical therapy (beta-blockers, verapamil), interventions for outflow obstruction (alcohol septal ablation, myectomy), and ICD implantation for high-risk patients.
Impact:
- Improved understanding of HCM's genetic underpinnings and clinical spectrum.
- Enhanced diagnostic and risk stratification approaches for HCM patients.
- Informed clinical decision-making for managing HCM and preventing sudden cardiac death.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a myocardial disorder characterized by left ventricular hypertrophy with no apparent cause (such as severe hypertension, aortic valve stenosis, etc.). The clinical diagnosis is based on cardiac imaging, commonly using 2D echocardiography and increasingly CMR. HCM is the leading cause of sudden death in young people, especially on the sports field. Many patients remain asymptomatic throughout life, while others develop heart failure, atrial fibrillation and stroke. HCM is the most common genetic (autosomal dominant) cardiovascular disease, with variable penetrance and expression. It is caused by mutations in genes coding for cardiac sarcomeric proteins. Genetic counseling and clinical risk stratification are crucial for all patients. Medical treatment with B-blockers or verapamil improves symptoms but has not been show to modify the clinical course. Patients with outflow obstruction and severe symptoms unresponsive to medical therapy are candidates for alcohol septal ablation or surgical myectomy. Current approaches focus on the prevention of sudden death by means of implantable defibrillators in high-risk patients.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology

